Dr. Doug delves into the role of DHEA (dehydroepiandrosterone) as a supplement, particularly its implications for cancer risk and bone health. He discusses the dual nature of DHEA, highlighting both its potential benefits and risks, especially in relation to cancers. Through various studies, he examines the association between DHEA levels and cancer, emphasizing the importance of understanding that correlation does not imply causation. Dr. Doug also addresses the complexities of using DHEA in patients with a history of cancer, advocating for a personalized approach to supplementation based on individual health profiles.